Home > News > IBN seeks venture capitalists
May 13th, 2005
IBN seeks venture capitalists
The Institute of Bioengineering and Nanotechnology (IBN) is looking for venture capitalists for a yet-to-be-named company that will deal in molecular diagnostics.
The IBN's executive director Prof Jackie Ying revealed the spin-off at the institute's official opening yesterday — exactly one year after it moved into the Biopolis.
Institute of Bioengineering and Nanotechnology
Nanometrics Announces Upcoming Investor Events July 28th, 2015
Harris & Harris Group Portfolio Company, Bridgelux, Enters into Agreement to be Acquired by an Investment Group July 22nd, 2015
Harris & Harris Group Portfolio Company, OpGen, Gains $6 Million Investment From Merck GHI in Addition to New Acquisition July 16th, 2015
Harris & Harris Group Portfolio Company, AgBiome, Announces Partnership to Accelerate the Discovery of Next Generation Insect-Resistant Crops July 1st, 2015
Nano Spray Instrument Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015
Nanocellulose Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015
Heating and cooling with light leads to ultrafast DNA diagnostics July 31st, 2015
Theoretical Physicists at Freie Universität Berlin Develop New Insights into Interface between Classical and Quantum Worlds July 31st, 2015